+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Nucleic Acid Nanostructures Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137599
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nucleic acid nanostructures market is advancing rapidly, presenting new opportunities across precision medicine, biotechnology, and molecular diagnostics. Senior decision-makers in life sciences, healthcare, and advanced manufacturing are now prioritizing strategies to navigate this dynamic sector driven by scientific innovation, industry collaboration, and regulatory evolution. The convergence of structure programmability, biocompatibility, and automated synthesis is reshaping the competitive landscape for both established and emerging organizations.

Market Snapshot: Nucleic Acid Nanostructures

The nucleic acid nanostructures market, characterized by its transformation from academic exploration to a robust commercial discipline, has witnessed significant global momentum. Innovations in design algorithms, scaffolded DNA origami, and hybrid DNA-RNA materials are enabling precisely engineered constructs, attracting major investments in molecular computation, biosensing, and stimuli-responsive systems. Accelerated prototyping and increased automation have reduced development timelines and opened new avenues for diagnostic and therapeutic applications.

Scope & Segmentation

This report provides a comprehensive analysis of the nucleic acid nanostructures market, examining trends in research, manufacturing, and commercialization. Detailed segmentation covers structure types, applications, end users, material types, synthesis approaches, regions, and key company activities.

  • Structure Types: DNA nanoribbons, nanowires, DNA origami (both two-dimensional and three-dimensional), tile and lattice constructs, and hybrid nucleic acid structures.
  • Application Areas: Biosensing and diagnostics (in vitro and in vivo), drug delivery (gene, protein, and small molecule), nanorobotics, and therapeutics.
  • End Users: Academic and research institutes, biotechnology companies, contract research organizations, pharmaceutical companies.
  • Material Types: DNA, hybrid DNA-RNA, and RNA.
  • Synthesis Approaches: Automated design and synthesis, scaffolded self-assembly, and tile-based assembly.
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East, Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, Takara Bio, Integrated DNA Technologies, Nitto Denko, Twist Bioscience, Origami Biosciences, Tilibit Nanosystems.

Key Takeaways for Senior Decision-Makers

  • Automated design platforms and high-throughput synthesis workflows drive faster prototyping, reducing material costs and increasing design iteration efficiency.
  • Collaborative industry–academia partnerships are accelerating translational research and enabling quicker commercialization of diagnostic and therapeutic solutions based on nucleic acid nanostructures.
  • Integrated RNA scaffolds and hybrid materials are broadening functional applications, supporting the development of devices for sensing, actuation, and targeted delivery.
  • Regulatory engagement and emerging quality-control protocols are streamlining approval pathways, helping companies align innovation with market entry requirements.
  • Strategic supply chain restructuring—especially dual sourcing and local production—mitigates risks from external shocks and ensures continuity for mission-critical programs.
  • Regional differences inform product positioning; North America’s focus on early adoption contrasts with Europe’s regulatory harmonization and Asia-Pacific’s manufacturing scale-up, affecting expansion strategies.

Tariff Impact: U.S. Tariffs Reshape Supply Chains

The 2025 U.S. tariffs on core input materials have led to cost increases for custom oligonucleotides and reagents, compelling market participants to renegotiate supplier agreements and establish buffer inventories. Organizations increasingly turn toward domestic or non-U.S. sources, while strategic inventory management and supplier diversification help maintain project continuity despite extended procurement timelines.

Methodology & Data Sources

This report employs a rigorous mixed-method approach, drawing on comprehensive secondary research of scientific publications, industry white papers, and patent filings. Primary interviews with subject matter experts from academic, industrial, and supply chain spheres supplemented qualitative insight, while scenario modeling and data triangulation ensured robust, validated findings.

Why This Report Matters

  • Identify key market drivers and competitive strategies to guide strategic investment and partnership decisions in nucleic acid nanostructures.
  • Understand the practical impacts of evolving regulatory, supply chain, and manufacturing dynamics across all major global regions.
  • Support risk management and opportunity assessment with clear segmentation and actionable recommendations tailored to senior leadership priorities.

Conclusion

Nucleic acid nanostructures present new frontiers for innovation across diagnostics, therapeutics, and advanced manufacturing. This report delivers clear, actionable intelligence for decision-makers committed to leading in this rapidly evolving field.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced computational modeling for precision design of DNA origami structures
5.2. Emerging regulatory frameworks addressing clinical translation of DNA and RNA nanocarriers
5.3. Development of multifunctional RNA nanostructures for targeted delivery and immunomodulation
5.4. Commercial scale manufacturing advances for stable and uniform nucleic acid nanostructure production
5.5. Innovative hybridization of nucleic acid nanostructures with inorganic nanoparticles for imaging
5.6. Advances in stimuli responsive nucleic acid nanodevices for controlled drug release applications
5.7. Design of self assembled DNA nanosensors for ultra sensitive detection of biomarkers in vivo
5.8. Integration of AI driven sequence optimization to enhance stability of nucleic acid nanostructures in physiological conditions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nucleic Acid Nanostructures Market, by Structure Type
8.1. Introduction
8.2. Dna Nanoribbons And Nanowires
8.3. Dna Origami
8.3.1. Three Dimensional
8.3.2. Two Dimensional
8.4. Dna Tiles And Lattices
8.5. Hybrid Nucleic Acid Nanostructures
9. Nucleic Acid Nanostructures Market, by Application
9.1. Introduction
9.2. Biosensing And Diagnostics
9.2.1. In Vitro Diagnostics
9.2.2. In Vivo Imaging
9.3. Drug Delivery
9.3.1. Gene Therapy
9.3.2. Protein Delivery
9.3.3. Small Molecule Delivery
9.4. Nanorobotics
9.5. Therapeutics
10. Nucleic Acid Nanostructures Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. Nucleic Acid Nanostructures Market, by Material Type
11.1. Introduction
11.2. Dna
11.3. Hybrid Dna Rna
11.4. Rna
12. Nucleic Acid Nanostructures Market, by Synthesis Approach
12.1. Introduction
12.2. Automated Design And Synthesis Platforms
12.3. Scaffolded Self Assembly
12.4. Tile Based Self Assembly
13. Americas Nucleic Acid Nanostructures Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Nucleic Acid Nanostructures Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Nucleic Acid Nanostructures Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific, Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Agilent Technologies, Inc.
16.3.5. Takara Bio Inc.
16.3.6. Integrated DNA Technologies, Inc.
16.3.7. Nitto Denko Corporation
16.3.8. Twist Bioscience Corporation
16.3.9. Origami Biosciences, Inc.
16.3.10. Tilibit Nanosystems GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NUCLEIC ACID NANOSTRUCTURES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NUCLEIC ACID NANOSTRUCTURES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NUCLEIC ACID NANOSTRUCTURES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NUCLEIC ACID NANOSTRUCTURES MARKET: RESEARCHAI
FIGURE 26. NUCLEIC ACID NANOSTRUCTURES MARKET: RESEARCHSTATISTICS
FIGURE 27. NUCLEIC ACID NANOSTRUCTURES MARKET: RESEARCHCONTACTS
FIGURE 28. NUCLEIC ACID NANOSTRUCTURES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEIC ACID NANOSTRUCTURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA NANORIBBONS AND NANOWIRES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA NANORIBBONS AND NANOWIRES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY THREE DIMENSIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY THREE DIMENSIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY TWO DIMENSIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY TWO DIMENSIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA TILES AND LATTICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA TILES AND LATTICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY HYBRID NUCLEIC ACID NANOSTRUCTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY HYBRID NUCLEIC ACID NANOSTRUCTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY IN VIVO IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY IN VIVO IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY PROTEIN DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY PROTEIN DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SMALL MOLECULE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SMALL MOLECULE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY NANOROBOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY NANOROBOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY HYBRID DNA RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY HYBRID DNA RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY AUTOMATED DESIGN AND SYNTHESIS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY AUTOMATED DESIGN AND SYNTHESIS PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SCAFFOLDED SELF ASSEMBLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SCAFFOLDED SELF ASSEMBLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY TILE BASED SELF ASSEMBLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY TILE BASED SELF ASSEMBLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 114. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 115. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 118. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 119. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 120. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 121. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 126. CANADA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 127. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 142. MEXICO NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 209. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 212. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 213. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 224. GERMANY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 225. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 228. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 229. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 240. FRANCE NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 257. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 260. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 261. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 266. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 267. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 270. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 271. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 272. ITALY NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 273. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 276. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 277. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 282. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 283. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 287. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 288. SPAIN NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DNA ORIGAMI, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY BIOSENSING AND DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY SYNTHESIS APPROACH, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA NUCLEIC ACID NANOSTRUCTURES MARKET SIZE, BY STRUCTURE TYPE, 2025-2030 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nucleic Acid Nanostructures market report include:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Integrated DNA Technologies, Inc.
  • Nitto Denko Corporation
  • Twist Bioscience Corporation
  • Origami Biosciences, Inc.
  • Tilibit Nanosystems GmbH